Author/Authors :
Alavian Seyed-Moayed نويسنده , Vafa Mohammad Reza نويسنده PhD, MSPH, Nutritional Sciences, Associate Professor, President of Iranian Nutrition Society, Iran University of Medical Sciences, Tehran , Jazayeri Shima نويسنده Department of Clinical Nutrition, School of Nutrition and Dietetics, Tehran University of Medical Sciences, Tehran , Mousavizadeh Kazem نويسنده Cellular and Molecular Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran. , Ghalichi Leila نويسنده Mental health research center, Iran University of Medical Sciences, Tehran, Iran. Ghalichi Leila , Tabatabaee Seyed Mohammad نويسنده Department of Nutrition, School of Public Health, Iran
University of Medical Sciences, Tehran, Iran , Miryounesi Seyed Mohammad نويسنده Genomic Research Center, Shahid Beheshti University of
Medical Sciences, Tehran, Iran
Abstract :
Objectives Antioxidant treatment with Iron chelating agents is one
of the suggested treatments for fatty liver disease, which has become an
important health problem in the recent decades. In this study the
authors evaluated the general antioxidant, iron chelating, and sugar and
fat absorption characteristics of green tea. Methods Patients with
non-alcoholic fatty liver disease were randomly assigned to 2 groups for
a double blind clinical trial. Patients in the intervention group
received 550 milligrams of green tea tablets daily as well as
nutritional education for 3 months. The control group received the same
protocol with green tea replaced with placebo tablets. Results After 3
months, 45 participants (21 in the intervention and 24 in the placebo
group) completed the follow-up. The change in body mass index (BMI),
aspartate aminotransferase (AST), and fasting blood sugar (FBS) was
significantly different between the 2 groups, while the change in total
iron binding capacity (TIBC), ferritin, alanine transaminase (ALT),
HOMA, and weight did not show a significant difference. Conclusions The
difference between the 2 groups was mainly observed in anthropometrics,
liver enzyme, and metabolic indicators, although the difference might
not have been highlighted due to the effectiveness of routine
treatments, that both groups received.
